Prótese total articulada de joelho utilizada no tratamento de osteossarcoma apendicular em cão Total articulated prosthesis for treatment of apendicular osteosarcoma in a dog

O objetivo do trabalho foi reportar o planejamento cirúrgico, a técnica operatória, a instrumentação e os resultados da substituição completa do terço médio distal do fêmur, do platô tibial e da articulação do joelho por prótese em um cão acometido por osteossarcoma no fêmur esquerdo. A prótese foi confeccionada em aço, apresentando três componentes articulados, mantendo o movimento semelhante à articulação do joelho. As porções femorais e tibiais da prótese foram cimentadas aos respectivos ossos, após ostectomia do fêmur e do platô tibial. O animal foi submetido a seis sessões de quimioterapia, com doxorrubicina e carboplatina, intercaladas mensalmente, objetivando inibir o crescimento de possíveis metástases pulmonares. Durante os seis primeiros dias, o animal apresentou neuropraxia e impotência funcional do membro. Aos 10 dias, o cão iniciou leve apoio e aos 30 dias já utilizava o membro pélvico de forma mais efetiva, porém, o ângulo de extensão da articulação foi reduzido de 150&deg; a 100&deg; devido à contratura muscular e à fibrose na região da fossa poplítea. Após um ano de observação, não houve melhora do ângulo de extensão do joelho, porém, o animal fazia uso do membro com claudicação. Aos 425 dias de pós-operatório, o animal veio a óbito por insuficiência renal. Nesse tempo não ocorreram metástases pulmonares ou locais visíveis radiograficamente, mas o proprietário não permitiu a realização da necropsia do paciente, sendo impossível confirmar outros dados que pudessem esclarecer melhor a causa morte. Conclui-se que a substituição total do joelho de cão é uma cirurgia factível, que permite a preservação e a utilização do membro após ressecção da neoplasia, embora outras pesquisas devam ser conduzidas para obtenção de melhores resultados pós-cirúrgicos.<br>This report describes the surgical technique, instrumentation and results of complete substitution of portion distal of the femur and knee articulation to prosthesis, in a dog with bone tumor in distal left femur. The prosthesis was made of steel, and composed by three articulated components with the goal of maintaining range of motion as a normal knee movement. The femoral and tibial prosthesis portions were fixed to the respective bones during the surgery, after femural and tibial plato ostectomy. The patient received six doses of adjuvant chemotherapy, composed by doxorrubicin monthly alternated with carboplatin. At six days after surgery the dog developed neuropraxy and non-weight bearing lameness. At 10 days the dog started to mild use of the limb and at 30 days it was more effective, but the extension of the stifle range was reduced by 100&deg; because of the fibrosis and muscle contracture on the popliteal fossa. At one year, this angle didn't improve but the dog continued to bear weight on the limb. At 425 days, the dog had died by renal failure. At this time, there was no evidence of local recurrence or distant metastasis, but the necropsy was declined by the owner, impairing the collection of more data. In conclusion, the replacement of total knee and half of the femur in dogs is possible and viable, but further study is warranted in order to obtain better technique and specific instrumentation, to attain better surgical outcomes

Polymeric nanoparticles as oral delivery systems for a grape pomace extract towards the improvement of biological activities

Grape pomace (GP) is a major by-product from the wine industry, known for its bioactive compounds and their impact upon gastrointestinal (GI) health. However, bioaccessibility is often poor due to their degradation during digestion. This work aimed to encapsulate bioactive GP extract (GPE) into chitosan (CS) and alginate (Alg) nanoparticles (NPs) to mitigate degradation in the GI tract. Alg and CS NPs were optimized using a rotatable central composite design and NPs were characterized for their size, polydispersity, zeta potential and total phenolics (TP) association efficiency. The best formulations showed sizes ranging 523–853 nm, polydispersity indexes of 0.11–0.36, zeta potential of −15.0–14.9 mV and TP association efficiencies of 68 and 65%. FTIR confirmed that there was no formation of new chemical groups after association of the polymers with GPE. Both formulations improved the bioaccessibility of different phenolics following in vitro GI digestion, leading to in-creased antioxidant and antimicrobial activities. Moreover, the permeability of bioactive compounds through a Caco-2/HT29-MTX co-culture was reduced, suggesting a higher residence time in the intestine. Cy5.5 was used for tracking the CS NPs, which did not affect the metabolic activity of Caco-2 and HT29-MTX cells. Confocal microscopy images confirmed the adsorption of NPs to the cellular layer and suggested a reduction of the tight junction protein occludin when cells were incubated with Cy5.5-CS in solution. This study suggests that encapsulation of GPE can offer protection against along the GI tract and improve its biological activity with significant impact for oral delivery applications, including functional foods.info:eu-repo/semantics/publishedVersio